Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.60
Bid: 76.80
Ask: 77.40
Change: -0.60 (-0.78%)
Spread: 0.60 (0.781%)
Open: 76.60
High: 77.00
Low: 76.60
Prev. Close: 77.20
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Timetable Update

7 Dec 2011 11:32

RNS Number : 5186T
GCP Infrastructure Investments Ltd
07 December 2011
 



 

 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN

 

This announcement does not constitute an offer to sell, or the solicitation of an offer to subscribe for or to buy, shares in any jurisdiction.

 

This announcement is neither an advertisement, a prospectus nor a financial promotion. Any investment in any shares referred to in this announcement may be made only on the basis of information in the prospectus (the "Prospectus") published on 22 November 2011 by GCP Infrastructure Investments Limited in connection with the proposed admission of its to be issued C shares of £0.01 each to the standard listing segment of the Official List of the UK Listing Authority and to trading on the Main Market for listed securities of the London Stock Exchange.

 

 

GCP Infrastructure Investments Limited (the "Company")

 

Timetable Update

 

7 December 2011

Further to the announcement made by the Company on 23 November 2011, announcing the publication of the Prospectus relating to the Company's proposed issue of C Shares of £0.01 each ("C Shares") by way of a placing and offer for subscription with a target size of £60m and an issue price of £1.00 per C Share (the "Issue"), the updated timetable for the Issue is as follows:

 

Latest time and date for receipt of Application Forms under the Offer for Subscription

11.00 a.m. on 15 December 2011

Latest time and date for receipt of Switching Application Forms

4.30 p.m. on 16 December 2011

Latest time and date for receipt of Placing commitments

4.30 p.m. on 16 December 2011

Announcement of the results of the Issue

 19 December 2011

Admission to the Official List and commencement of dealings on the London Stock Exchange

8.00 a.m. on 22 December 2011

CREST accounts credited

by 22 December 2011

Despatch of definitive share certificates (where applicable)

week commencing 26 December 2011

 

Words and expressions that are defined in the Prospectus shall have the same meanings where they are used in this announcement, except where the context requires otherwise.

 

 

END

 

Contact details:

 

Gravis Capital Partners LLP

Stephen Ellis

+44 (0)20 7518 1495

Rollo Wright

+44 (0)20 7518 1493

Oriel Securities

Emma Griffin

+44 (0)20 7710 7600

Joe Winkley

Gareth Price

Neil Winward

MHP Communications

Martin Forrest

+44 (0)20 3128 8590

 

 

This announcement is not for distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada or Japan. This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada or Japan. The securities of the Company have not been and will not be registered under the U.S. Securities Act of 1933 (the "Securities Act") and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada or Japan and, subject to certain exceptions, may not be offered or sold within Australia, Canada or Japan or to any national, resident or citizen of Australia, Canada or Japan.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFSFFFWFFSEDE
Date   Source Headline
8th May 20247:00 amRNSInvestor Report at 31 March 2024
26th Apr 20244:53 pmRNSDirector/PDMR Shareholding
26th Apr 20244:51 pmRNSDirector/PDMR Shareholding
26th Apr 20247:00 amRNSWind Disposal and Capital Allocation Policy Update
25th Apr 20247:00 amRNSCompany update, NAV and dividend declaration
20th Feb 20247:00 amRNSRevolving Credit Facility
15th Feb 20244:22 pmRNSDirector/PDMR Shareholding
14th Feb 20241:31 pmRNSResult of Annual General Meeting
2nd Feb 20247:00 amRNSInvestor Report at 31 December 2023
31st Jan 202412:56 pmRNSAnnual Overview from QuotedData
29th Jan 20247:00 amRNSCompany Update, NAV and Dividend Declaration
17th Jan 20249:15 amRNSNotice of Annual General Meeting
16th Jan 20241:53 pmRNSForm 8.3 - [GCP ASSET BACKED INCOME INV TST LTD]
13th Dec 20237:00 amRNSAnnual report and financial statements
12th Dec 20234:15 pmRNSHolding(s) in Company
11th Dec 20234:37 pmRNSHolding(s) in Company
5th Dec 20235:39 pmRNSHolding(s) in Company
30th Nov 20235:35 pmRNSTotal Voting Rights
30th Nov 20234:35 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSInvestor report at 30 September 2023
13th Nov 20237:00 amRNSCompliance with Market Abuse Regulation
10th Nov 20235:07 pmRNSTransaction in Own Shares
6th Nov 20235:30 pmRNSDirector/PDMR Shareholding
2nd Nov 20237:00 amRNSDividend Declaration
31st Oct 20235:14 pmRNSTotal Voting Rights
27th Oct 20235:04 pmRNSTransaction in Own Shares
26th Oct 20235:34 pmRNSTransaction in Own Shares
24th Oct 20235:09 pmRNSTransaction in Own Shares
23rd Oct 20233:30 pmRNSDirector/PDMR Shareholding
23rd Oct 20237:00 amRNSCompany update and net asset value(s)
20th Oct 20235:09 pmRNSTransaction in Own Shares
19th Oct 20235:06 pmRNSTransaction in Own Shares
18th Oct 20235:25 pmRNSTransaction in Own Shares
17th Oct 20235:30 pmRNSTransaction in Own Shares
11th Oct 20235:22 pmRNSTransaction in Own Shares
10th Oct 20235:29 pmRNSTransaction in Own Shares
10th Oct 20237:00 amRNSAppointment of Joint Corporate Broker
9th Oct 20235:22 pmRNSDirector/PDMR Shareholding
4th Oct 20235:31 pmRNSTransaction in Own Shares
3rd Oct 20235:13 pmRNSTransaction in Own Shares
2nd Oct 20234:50 pmRNSTransaction in Own Shares
28th Sep 20235:01 pmRNSTransaction in Own Shares
28th Sep 20234:31 pmRNSHolding(s) in Company
27th Sep 20235:18 pmRNSTransaction in Own Shares
26th Sep 20235:21 pmRNSTransaction in Own Shares
25th Sep 20235:40 pmRNSTransaction in Own Shares
22nd Sep 20235:38 pmRNSTransaction in Own Shares
22nd Sep 20235:35 pmRNSHolding(s) in Company
21st Sep 20235:11 pmRNSTransaction in Own Shares
20th Sep 20235:10 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.